Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
NAII 
Natural Alternatives International (NAII)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/20/2025: NAII (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $
1 Year Target Price $
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -50.89% | Avg. Invested days 18 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/20/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 19.90M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.63 | 52 Weeks Range 2.57 - 6.88 | Updated Date 06/29/2025 |
52 Weeks Range 2.57 - 6.88 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.39 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -6.56% | Operating Margin (TTM) 7.87% |
Management Effectiveness
Return on Assets (TTM) -3.75% | Return on Equity (TTM) -10.25% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 67902418 | Price to Sales(TTM) 0.16 |
Enterprise Value 67902418 | Price to Sales(TTM) 0.16 | ||
Enterprise Value to Revenue 0.54 | Enterprise Value to EBITDA 74.97 | Shares Outstanding 6178900 | Shares Floating 4878116 |
Shares Outstanding 6178900 | Shares Floating 4878116 | ||
Percent Insiders 21.59 | Percent Institutions 33.51 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Natural Alternatives International
Company Overview
History and Background
Natural Alternatives International (NAII) was founded in 1980. It began as a contract manufacturer for dietary supplements and has evolved to focus on scientifically based nutritional products and custom contract manufacturing services.
Core Business Areas
- Contract Manufacturing: NAII provides contract manufacturing services for nutritional supplement companies, including formulation, blending, tableting, encapsulation, and packaging.
- Branded Products: NAII develops and markets its own branded nutritional supplements, primarily focused on sports nutrition and wellness categories.
Leadership and Structure
Mark A. LeDoux serves as the Chairman and CEO. The company has a typical corporate structure with various departments for operations, sales, marketing, finance, and research & development.
Top Products and Market Share
Key Offerings
- CarnoSynthesize Beta-Alanine: A patented beta-alanine ingredient used in sports nutrition products to enhance muscle endurance and performance. Market share information specifically for CarnoSynthesize is not publicly available, but beta-alanine supplements are competitive. Competitors include NNB Nutrition (through its Beta-Prime product). Revenue from beta-alanine likely constitutes a significant portion of NAII's ingredient sales.
- Branded Sports Nutrition Supplements: NAII develops and markets a range of sports nutrition supplements under various brand names. Market share data for NAII's specific brands is limited. Competition is fierce and includes brands such as Optimum Nutrition (Glanbia), MuscleTech (Iovate Health Sciences), and Cellucor (Nutrabolt).
Market Dynamics
Industry Overview
The dietary supplement industry is experiencing growth driven by increasing consumer interest in health and wellness, aging populations, and a focus on preventative healthcare. Trends include personalized nutrition, plant-based supplements, and e-commerce sales channels.
Positioning
NAII is positioned as a high-quality contract manufacturer and branded supplement provider with a focus on scientific validation. Its competitive advantages include its patented ingredients, manufacturing expertise, and long-standing relationships with customers.
Total Addressable Market (TAM)
The global dietary supplements market is estimated to be over $200 billion. NAII's positioning in contract manufacturing and branded supplements allows it to capture a part of this market, with significant opportunity in specialized ingredients and sports nutrition.
Upturn SWOT Analysis
Strengths
- Patented Ingredients (CarnoSyn)
- Strong R&D Capabilities
- Established Contract Manufacturing Relationships
- High-Quality Manufacturing Standards
- Experienced Management Team
Weaknesses
- Limited Brand Recognition Compared to Larger Competitors
- Reliance on Key Customers
- Smaller Marketing Budget
- Vulnerable to Raw Material Price Fluctuations
Opportunities
- Expanding into New International Markets
- Developing New Patented Ingredients
- Acquiring Complementary Businesses
- Growing Demand for Personalized Nutrition
- Increase Direct to Consumer sales
Threats
- Increased Competition from Larger Players
- Changing Regulatory Environment
- Economic Downturn Affecting Consumer Spending
- Raw Material Supply Chain Disruptions
- Negative Publicity Regarding Supplement Safety
Competitors and Market Share
Key Competitors
- Glanbia (GLB.I)
- Nutrabolt (Private)
- Iovate Health Sciences (Private)
Competitive Landscape
NAII competes with larger, more diversified companies. Its advantages include specialized ingredients like CarnoSynthesize and its contract manufacturing expertise. Disadvantages include lower brand recognition and marketing resources.
Growth Trajectory and Initiatives
Historical Growth: Past growth has been driven by contract manufacturing and sales of CarnoSynthesize. Fluctuations can occur based on customer demand and economic cycles.
Future Projections: Future growth is projected to come from expanding its customer base, developing new ingredients, and leveraging its manufacturing capabilities.
Recent Initiatives: Recent initiatives include focusing on direct-to-consumer sales and expanding internationally.
Summary
Natural Alternatives International is a smaller player in the nutritional supplement industry with strengths in contract manufacturing and patented ingredients. Its growth potential is tied to expanding its customer base and developing new products. Competition from larger companies and regulatory changes pose challenges. Its main advantage lies in its specialized ingredients and custom manufacturing capabilities.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Financial News Outlets
Disclaimers:
The information provided is for informational purposes only and does not constitute financial advice. Market share estimates are approximate and based on available data.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Natural Alternatives International
Exchange NASDAQ | Headquaters Carlsbad, CA, United States | ||
IPO Launch date 1987-03-13 | Chairman of the Board & CEO Mr. Mark A. LeDoux J.D. | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 296 | Website https://www.nai-online.com |
Full time employees 296 | Website https://www.nai-online.com | ||
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, the company sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.